Clinical Trials Directory

Trials / Completed

CompletedNCT04142489

In Vivo Damage Induced bu UV in the Epidermis of the Scalp

Clinical Study of In Vivo Damage Induced bu UV in the Epidermis of the Scalp

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Centre Hospitalier Universitaire de Nice · Academic / Other
Sex
Male
Age
40 Years – 60 Years
Healthy volunteers
Accepted

Summary

Squamous cell carcinomas (SCC) are the second most common skin cancer in humans. The incidence of SCCs in the USA in 2012 was estimated at 700,000 casesSCCs have a metastatic course in 3% to 5% of cases that is of poor prognosis. In men, the SCCs of the scalp represent the most frequent location of the head and neck, the 3rd location of the whole body. The SCCs of the scalp are more undifferentiated than in other locations. In addition, actinic keratoses of scalp, precursors of SCC, are more resistant to treatment than in other areas. These particularities of the SCCs of the scalp suggest the existence of specific factors at the epidermis level of the scalp. UV-induced damage to DNA is the defining event in skin photocarcinogenesis. It has already been shown that DNA damage induced by UV and the kinetics of repair of this damage may vary with age or phototype of patients, but the topographic variation of DNA damage has never been studied, although it is known that gene expression in skin cells may differ from one region of the body to another. the hypothesis is therefore that the particular characteristics of KAs and SCCs at the scal level could be explained by an increased sensitivity to UV-induced damage. It is planned to study UV-induced damage and its repair at the scalp level in humans compared to the forearm.

Conditions

Interventions

TypeNameDescription
OTHERsolar irradiation and biopsiesthe minimum erythematous dose (DEM) will be calculated using a solar irradiator on the scalp (study area) and on a forearm (control area). On D2 (D1+24h) a solar irradiation corresponding to 2 DEM will be performed on a region of the scalp (studied area), as well as on a forearm (control area). A 3mm biopsy will be performed 15mn after irradiation in these 2 regions to study DNA damage. At D4 (D2+48h) a 2nd biopsy of 3 mm will be performed to study the repair of induced DNA damage.

Timeline

Start date
2021-02-01
Primary completion
2021-05-10
Completion
2021-07-01
First posted
2019-10-29
Last updated
2022-05-06

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04142489. Inclusion in this directory is not an endorsement.